Genome's

But Human Genome's fortunes may lie on a potential blockbuster treatment for lupus, a notoriously hard-to-treat autoimmune disease that hasn't seen a new therapy in decades.

Human Genome Director Southwell to Be Finance Chief Kevin Kingsbury 2010

But Human Genome's fortunes may lie on a potential blockbuster treatment for lupus, a notoriously hard-to-treat autoimmune disease that hasn't seen a new therapy in decades.

Human Genome Director Southwell to Be Finance Chief Kevin Kingsbury 2010

But Human Genome's fortunes may lie on a potential blockbuster treatment for lupus, a notoriously hard-to-treat autoimmune disease that hasn't seen a new therapy in decades.

Human Genome Director Southwell to Be Finance Chief Kevin Kingsbury 2010

At current prices, the call options make money if Human Genome's stock climbs above $21.85.

Takeover Talk Has Bulls Buying Human Genome 2009

Of course, given Human Genome's less-than-stellar fundamentals, only speculative-types should consider getting involved.

unknown title 2011

When Human Genome's Benlysta was approved, the FDA mandated further safety studies be done.

unknown title 2011

Human Genome's Benlysta for lupus patients with moderate to severe systemic disease will cost about $35,000 a year, David Southwell, the company's chief financial officer, said at a Sept. 15 investor conference.

unknown title 2011

It could be said that Lord Genome's eventual failure was attributed to the lack of quality performance from his beastmen, whereas we could see the Dai Gurren-Dan as a team of Six Sigma fighters who are extra-proficient in their goal achievements.

Anime Nano! 2010

It could be said that Lord Genome's eventual failure was attributed to the lack of quality performance from his beastmen, whereas we could see the Dai Gurren-Dan as a team of Six Sigma fighters who are extra-proficient in their goal achievements.

Anime Nano! 2010

The strangle results in a gross premium of $1.62 per contract, which the trader keeps if Human Genome's shares trade within the confines of the strike prices described through expiration day.

FXstreet.com 2010